These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 11920419)
1. The beneficial effect of interleukin-12 on arthritis induced by group B streptococci is mediated by interferon-gamma and interleukin-10 production. Puliti M; von Hunolstein C; Bistoni F; Mosci P; Orefici G; Tissi L Arthritis Rheum; 2002 Mar; 46(3):806-17. PubMed ID: 11920419 [TBL] [Abstract][Full Text] [Related]
2. Influence of interferon-gamma administration on the severity of experimental group B streptococcal arthritis. Puliti M; von Hunolstein C; Bistoni F; Mosci P; Orefici G; Tissi L Arthritis Rheum; 2000 Dec; 43(12):2678-86. PubMed ID: 11145025 [TBL] [Abstract][Full Text] [Related]
3. Role of interleukin-18 in experimental group B streptococcal arthritis. Tissi L; McRae B; Ghayur T; von Hunolstein C; Orefici G; Bistoni F; Puliti M Arthritis Rheum; 2004 Jun; 50(6):2005-13. PubMed ID: 15188378 [TBL] [Abstract][Full Text] [Related]
4. Contribution of matrix metalloproteinase 2 to joint destruction in group B Streptococcus-induced murine arthritis. Puliti M; Momi S; Falcinelli E; Gresele P; Bistoni F; Tissi L Arthritis Rheum; 2012 Apr; 64(4):1089-97. PubMed ID: 22042442 [TBL] [Abstract][Full Text] [Related]
5. Down-regulation of Th1-mediated pathology in experimental arthritis by stimulation of the Th2 arm of the immune response. Mauri C; Feldmann M; Williams RO Arthritis Rheum; 2003 Mar; 48(3):839-45. PubMed ID: 12632440 [TBL] [Abstract][Full Text] [Related]
6. Mechanisms of effects of complement inhibition in murine collagen-induced arthritis. Banda NK; Kraus D; Vondracek A; Huynh LH; Bendele A; Holers VM; Arend WP Arthritis Rheum; 2002 Nov; 46(11):3065-75. PubMed ID: 12428251 [TBL] [Abstract][Full Text] [Related]
7. Staphylococcus aureus-induced septic arthritis and septic death is decreased in IL-4-deficient mice: role of IL-4 as promoter for bacterial growth. Hultgren O; Kopf M; Tarkowski A J Immunol; 1998 May; 160(10):5082-7. PubMed ID: 9590259 [TBL] [Abstract][Full Text] [Related]
8. MDMA ("Ecstasy") suppresses the innate IFN-gamma response in vivo: a critical role for the anti-inflammatory cytokine IL-10. Boyle NT; Connor TJ Eur J Pharmacol; 2007 Oct; 572(2-3):228-38. PubMed ID: 17689526 [TBL] [Abstract][Full Text] [Related]
10. Mice with the xid B cell defect are less susceptible to developing Staphylococcus aureus-induced arthritis. Zhao YX; Abdelnour A; Holmdahl R; Tarkowski A J Immunol; 1995 Aug; 155(4):2067-76. PubMed ID: 7636257 [TBL] [Abstract][Full Text] [Related]
11. Different amplifying mechanisms of interleukin-17 and interferon-gamma in Fcgamma receptor-mediated cartilage destruction in murine immune complex-mediated arthritis. Grevers LC; van Lent PL; Koenders MI; Walgreen B; Sloetjes AW; Nimmerjahn F; Sjef Verbeek J; van den Berg WB Arthritis Rheum; 2009 Feb; 60(2):396-407. PubMed ID: 19180490 [TBL] [Abstract][Full Text] [Related]
12. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510 [TBL] [Abstract][Full Text] [Related]
13. Activation of invariant NKT cells confers protection against Chlamydia trachomatis-induced arthritis. Bharhani MS; Chiu B; Na KS; Inman RD Int Immunol; 2009 Jul; 21(7):859-70. PubMed ID: 19477915 [TBL] [Abstract][Full Text] [Related]
14. Impact of interferon-gamma receptor deficiency on experimental Staphylococcus aureus septicemia and arthritis. Zhao YX; Tarkowski A J Immunol; 1995 Dec; 155(12):5736-42. PubMed ID: 7499861 [TBL] [Abstract][Full Text] [Related]
15. The effects of interferon-gamma and transforming growth factor-beta on adherence and survival of group B Streptococcus type III strains in ECV304 cells. Santos GS; Miyazaki NH; Mattos-Guaraldi AL; Nagao PE Int J Mol Med; 2003 Mar; 11(3):401-6. PubMed ID: 12579348 [TBL] [Abstract][Full Text] [Related]
16. Severity of group B streptococcal arthritis in selected strains of laboratory mice. Puliti M; Bistoni F; von Hunolstein C; Orefici G; Tissi L Infect Immun; 2001 Jan; 69(1):551-5. PubMed ID: 11119551 [TBL] [Abstract][Full Text] [Related]
17. Shift from toll-like receptor 2 (TLR-2) toward TLR-4 dependency in the erosive stage of chronic streptococcal cell wall arthritis coincident with TLR-4-mediated interleukin-17 production. Abdollahi-Roodsaz S; Joosten LA; Helsen MM; Walgreen B; van Lent PL; van den Bersselaar LA; Koenders MI; van den Berg WB Arthritis Rheum; 2008 Dec; 58(12):3753-64. PubMed ID: 19035506 [TBL] [Abstract][Full Text] [Related]
19. Role of tumor necrosis factor alpha, interleukin-1beta, and interleukin-6 in a mouse model of group B streptococcal arthritis. Tissi L; Puliti M; Barluzzi R; Orefici G; von Hunolstein C; Bistoni F Infect Immun; 1999 Sep; 67(9):4545-50. PubMed ID: 10456898 [TBL] [Abstract][Full Text] [Related]
20. Intranasal IL-12 produces discreet pulmonary and systemic effects on allergic inflammation and airway reactivity. Matsuse H; Kong X; Hu J; Wolf SF; Lockey RF; Mohapatra SS Int Immunopharmacol; 2003 Apr; 3(4):457-68. PubMed ID: 12689651 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]